Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven T Staben

Showing results (41-50 of 44) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 44 results.
Journal of Medicinal Chemistry|June 26, 2018
Scaffold-Hopping Approach To Discover Potent, Selective, and Efficacious Inhibitors of NF-κB Inducing KinaseNicole Blaquiere, Georgette M Castanedo, Jason D Burch, et al.
Journal of Medicinal Chemistry|February 17, 2021
Antibody-Mediated Delivery of Chimeric BRD4 Degraders. Part 1: Exploration of Antibody Linker, Payload Loading, and Payload Molecular PropertiesPeter S Dragovich, Thomas H Pillow, Robert A Blake, et al.
Nature Communications|January 14, 2018
NF-κB inducing kinase is a therapeutic target for systemic lupus erythematosusHans D Brightbill, Eric Suto, Nicole Blaquiere, et al.
Bioorganic & Medicinal Chemistry Letters|January 7, 2020
Antibody-mediated delivery of chimeric protein degraders which target estrogen receptor alpha (ERα)Peter S Dragovich, Pragya Adhikari, Robert A Blake, et al.
Pageof 5

Showing results (41-50 of 44) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 44 results.
Journal of Medicinal Chemistry|June 26, 2018
Scaffold-Hopping Approach To Discover Potent, Selective, and Efficacious Inhibitors of NF-κB Inducing KinaseNicole Blaquiere, Georgette M Castanedo, Jason D Burch, et al.
Journal of Medicinal Chemistry|February 17, 2021
Antibody-Mediated Delivery of Chimeric BRD4 Degraders. Part 1: Exploration of Antibody Linker, Payload Loading, and Payload Molecular PropertiesPeter S Dragovich, Thomas H Pillow, Robert A Blake, et al.
Nature Communications|January 14, 2018
NF-κB inducing kinase is a therapeutic target for systemic lupus erythematosusHans D Brightbill, Eric Suto, Nicole Blaquiere, et al.
Bioorganic & Medicinal Chemistry Letters|January 7, 2020
Antibody-mediated delivery of chimeric protein degraders which target estrogen receptor alpha (ERα)Peter S Dragovich, Pragya Adhikari, Robert A Blake, et al.
Pageof 5